Inverse relationship between raft LRP1 localization and non-raft ERK1,2/MMP9 activation in idiopathic dilated cardiomyopathy: Potential impact in ventricular remodeling

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 805-814

  Roura, Santiago ^a   Cal, Roi ^b   Gálvez Montón, Carolina ^a   Revuelta Lopez, Elena ^b   Nasarre, Laura ^b   Badimon, Lina ^b   Bayes Genis, Antoni ^a,c,d   Llorente Cortés, Vicenta ^b  

^a FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

^b CSIC   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

ERK; Idiopathic dilated cardiomyopathy; Lipid rafts; LRP1; Membrane compartmentalisation; MMP

Indexed keywords

GELATINASE B; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LRP1 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN;

ADULT; ANIMAL; CARDIOMYOPATHY, DILATED; CELL LINE; CELL MEMBRANE; CHEMISTRY; ENZYME ACTIVATION; FEMALE; HEART VENTRICLE REMODELING; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; CARDIOMYOPATHY, DILATED; CELL LINE; ENZYME ACTIVATION; FEMALE; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MEMBRANE MICRODOMAINS; MICE; MIDDLE AGED; VENTRICULAR REMODELING;

EID: 84908230905     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.270     Document Type: Article

References (44)

1. B.J. Maron, J.A. Towbin, and G. Thiene Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
2. S. Roura, and A. Bayes-Genis Vascular dysfunction in idiopathic dilated cardiomyopathy Nat Rev Cardiol 6 2009 590 598
3. J.L. Jefferies, and J.A. Towbin Dilated cardiomyopathy Lancet 375 2010 752 762
4. Z. Gunja-Smith, Z. Gunja-Smith, A.R. Morales, R. Romanelli, and J.F. Woessner Jr. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links Am J Pathol 148 1996 1639 1648
5. M.M. Marijianowski, P. Teeling, J. Mann, and A. Becker Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment J Am Coll Cardiol 25 1995 1263 1272
6. M. Pauschinger, D. Knopf, and S. Petschauer Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio Circulation 99 1999 2750 2756
7. A.L. Müller, and N.S. Dhalla Role of various proteases in cardiac remodeling and progression of heart failure Heart Fail Rev 17 2012 395 409
8. J. Díez Altered degradation of extracellular matrix in myocardial remodelling: the growing role of cathepsins and cystatins Cardiovasc Res 87 2010 591 592
9. C.V. Thomas, M.L. Coker, J.L. Zellner, J.R. Handy, A.J. Crumbley III, and F.G. Spinale Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy Circulation 97 1998 1708 1715
10. P.W. Fedak, C.S. Moravec, and P.M. McCarthy Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy Circulation 113 2006 238 245
11. P. Sivakumar, S. Gupta, S. Sarkar, and S. Sen Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy Mol Cell Biochem 307 2008 159 167
12. V. Montel, A. Gaultier, R.D. Lester, W.M. Campana, and S.L. Gonias The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development Cancer Res 67 2007 9817 9824
13. H. Song, Y. Li, J. Lee, A.L. Schwartz, and G. Bu Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9 Cancer Res 69 2009 879 886
14. E. Hahn-Dantona, J.F. Ruiz, P. Bornstein, and D.K. Strickland The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism J Biol Chem 276 2001 15498 15503
15. C.D. Overton, P.G. Yancey, A.S. Major, M.F. Linton, and S. Fazio Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse Circ Res 100 2007 670 677
16. K. Hu, J. Yang, S. Tanaka, S.L. Gonias, W.M. Mars, and Y. Liu Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression J Biol Chem 281 2006 2120 2127
17. L. Wu, and S.L. Gonias The low-density lipoprotein receptor-related protein-1 associates transiently with lipid rafts J Cell Biochem 96 2005 1021 1033
18. L.J. Pike Lipid rafts: bringing order to chaos J Lipid Res 44 2003 655 667
19. K. Simons, and E. Ikonen Functional rafts in cell membranes Nature 387 1997 569 572
20. N. Geetha, J. Mihaly, and A. Stockenhuber Signal integration and coincidence detection in the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) cascade: concomitant activation of receptor tyrosine kinases and of LRP-1 leads to sustained ERK phosphorylation via down-regulation of dual specificity phosphatases (DUSP1 and -6) J Biol Chem 286 2011 25663 25674
21. B. Langlois, G. Perrot, and C. Schneider LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways PLoS One 5 2010 e11584
22. S.C. Muratoglu, I. Mikhailenko, C. Newton, M. Migliorini, and D.K. Strickland Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activation of the MAPK pathway J Biol Chem 285 2010 14308 14317
23. S. Haq, G. Choukroun, and H. Lim Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure Circulation 103 2001 670 677
24. W. Wu, A. Muchir, J. Shan, G. Bonne, and H.J. Worman Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene Circulation 123 2011 53 61
25. B. Poudel, D.K. Kim, H.H. Ki, Y.B. Kwon, Y.M. Lee, and D.K. Kim Downregulation of ERK signaling impairs U2OS osteosarcoma cell migration in collagen matrix by suppressing MMP9 production Oncol Lett 7 2014 215 218
26. J.H. Kim, J.H. Kim, and S.C. Kim Adenosine dialdehyde suppresses MMP-9-mediated invasion of cancer cells by blocking the Ras/Raf-1/ERK/AP-1 signaling pathway Biochem Pharmacol 86 2013 1285 1300
27. E.J. Lee, S.J. Lee, and S. Kim Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression Cell Signal 25 2013 2025 2038
28. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
29. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
30. S. Roura, C. Gálvez-Montón, and J.M. Pujal New insights into lipid raft function regulating myocardial vascularization competency in human idiopathic dilated cardiomyopathy Atherosclerosis 230 2013 354 364
31. V. Llorente-Cortés, M. Otero-Viñas, S. Sánchez, C. Rodríguez, and L. Badimon Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism Circulation 106 2002 3104 3110
32. S.M. White, P.E. Constantin, and W.C. Claycomb Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function Am J Physiol Heart Circ Physiol 286 2004 H823 H829
33. R. Cal, J. Castellano, and E. Revuelta-López Low-density lipoprotein receptor-related protein 1 mediates hypoxia-induced very low density lipoprotein-cholesteryl ester uptake and accumulation in cardiomyocytes Cardiovasc Res 94 2012 469 479
34. L.C. Cáceres, G.R. Bonacci, M.C. Sánchez, and G.A. Chiabrando Activated α(2) macroglobulin induces matrix metalloproteinase 9 expression by low-density lipoprotein receptor-related protein 1 through MAPK-ERK1/2 and NF-κB activation in macrophage-derived cell lines J Cell Biochem 111 2010 607 617
35. D.J. Webb, D.H. Nguyen, and S.L. Gonias Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion J Cell Sci 113 Pt 1 2000 123 134
36. V. Llorente-Cortes, V. Barbarigo, and L. Badimon Low density lipoprotein receptor-related protein 1 modulates the proliferation and migration of human hepatic stellate cells J Cell Physiol 227 2012 3528 3533
37. Z. Ma, K.S. Thomas, and D.J. Webb Regulation of Rac1 activation by the low density lipoprotein receptor-related protein J Cell Biol 159 2002 1061 1070
38. B. Casar, I. Arozarena, and V. Sanz-Moreno Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins Mol Cell Biol 29 2009 1338 1353
39. F.G. Spinale, M.L. Coker, and L.J. Heung A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure Circulation 102 2000 1944 1949
40. M. Franz, A. Berndt, and D. Neri Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B + tenascin-C and ED-A + fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosis Int J Cardiol 168 2013 5344 5351
41. Y. Matsumoto, I.K. Park, and K. Kohyama Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy J Immunol 183 2009 4773 4781
42. D. Reinhardt, H.H. Sigusch, J. Hensse, S.C. Tyagi, R. Körfer, and H.R. Figulla Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP Heart 88 2002 525 530
43. Y.C. Cheng, L.M. Chen, and M.H. Chang Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells Mol Cell Biochem 325 2009 15 23
44. E. Braunwald Heart failure JACC Heart Fail 1 2013 1 20